1-4 of 4
Ingrid Arvidsson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Landmark Analysis of Imatinib Treatment in CML Chronic Phase: ES-FISH <10% Ph+ At 3 Months Associated with Better Cytogenetic Response and Improved Long-Term Event-Free Survival

Anne-Charlotte Ohm, M.D., Gisela Barbany, MD, PhD, Ingrid Arvidsson, Lab., tech., Robert Hast, M.D., Ph.D., Leif Stenke, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1702.
https://doi.org/10.1182/blood.V118.21.1702.1702
Published: 2011
Journal Articles

Landmark Analyses of BCR-ABL Using ES-FISH Early After Start of Imatinib Treatment to Newly Diagnosed CMLcp Patients Predicts Longterm Clinical Outcome.

Lotta Ohm, MD, Robert Hast, MD, PhD, Ingrid Arvidsson, Gisela Barbany, Leif Stenke, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4269.
https://doi.org/10.1182/blood.V114.22.4269.4269
Published: 2009
Journal Articles

Involvement and functional impairment of the CD34 + CD38 − Thy-1 + hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8

Lars Nilsson, Ingbritt Åstrand-Grundström, Kristina Anderson, Ingrid Arvidsson, Peter Hokland, David Bryder, Lars Kjeldsen, Bertil Johansson, Eva Hellström-Lindberg, Robert Hast, Sten Eirik W. Jacobsen
Journal: Blood
Blood (2002) 100 (1): 259–267.
https://doi.org/10.1182/blood-2001-12-0188
Published: 2002
Journal Articles

Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level

Lars Nilsson, Ingbritt Åstrand-Grundström, Ingrid Arvidsson, Björn Jacobsson, Eva Hellström-Lindberg, Robert Hast, Sten E. W. Jacobsen
Journal: Blood
Blood (2000) 96 (6): 2012–2021.
https://doi.org/10.1182/blood.V96.6.2012
Published: 2000